These 3 revolutionary genomics companies are changing lives for patients — and investors By: MarketWatch May 09, 2019 at 05:20 AM EDT Use of genetic testing is soaring, and so are these stocks, writes Michael Brush. Read More >> Related Stocks: Alnylam Pharmaceuticals Ark Genomic Revolution ETF Ark Innovation ETF Astrazeneca Plc ADR Biomarin Pharmaceuticals Genomic Health Inc Invitae Corp Jazz Pharma Plc Johnson & Johnson Merck & Co Myokardia Inc Nasdaq Biotechnology Ishares ETF Range Cancer Therapeutics Index S&P Biotech SPDR Takeda Pharmaceutical Ltd ADR Veracyte Inc